PHARMA TECHNOLOGY A/S
CVR 20826746 · Public limited company (A/S) · Active · Low risk
PHARMA TECHNOLOGY A/S is a Public limited company (A/S), founded on , based in Køge. The company is registered in the industry rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 20 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 12.8m and a net result of DKK 12.3m. CEO: Flemming Sten Pedersen.
Bankruptcy risk for PHARMA TECHNOLOGY A/S
0.0 × the average (1.41%) · higher risk than 33% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 20826746
- Status
- Active
- Company type
- Public limited company (A/S)
- Founded
- (28 years)
- Address
- Åshøjvej 24
4600 Køge - Municipality
- Køge
- Industry
- Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik (711220)
Bankruptcies in the industry: Rådgivende ingeniørvirksomhed inden for byggeri og anlægsarbejder - Share capital
- DKK 500k
- Employees
- 5 (2018)
- Auditor
- Revisionskontoret i Faxe
- Audit opted out
- No
Warning signs
| Annual reports filed late | 3 of 28 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 37.6% |
| Current ratio | 160% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 0 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 2 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 |
|---|---|---|
| Gross profit | DKK 48.3m | DKK 34.0m |
| Net profit | DKK 12.3m | DKK 9.0m |
| Equity | DKK 12.8m | DKK 9.5m |
| Total assets | DKK 34.1m | DKK 26.2m |
| Cash | DKK 5.0m | – |
| Short-term debt | DKK 21.3m | – |
| Avg. employees | 0 | – |
Latest annual report: Reporting class B · auditor's statement: Revisionspåtegning · Sønderup Godkendt Revisionsaktieselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 178 | ||
| 1 Jan 2024 – 31 Dec 2024 | 143 | ||
| 1 Jan 2023 – 31 Dec 2023 | 129 | ||
| 1 Jan 2022 – 31 Dec 2022 | 137 | ||
| 1 Jan 2021 – 31 Dec 2021 | 182 | ||
| 1 Jan 2020 – 31 Dec 2020 | 153 | ||
| 1 Jan 2019 – 31 Dec 2019 | 128 | ||
| 1 Jan 2018 – 31 Dec 2018 | 151 | ||
| 1 Jan 2017 – 31 Dec 2017 | 155 | ||
| 1 Jan 2016 – 31 Dec 2016 | 158 | ||
| 1 Jan 2015 – 31 Dec 2015 | 150 | ||
| 1 Jan 2014 – 31 Dec 2014 | 155 | ||
| 1 Jan 2013 – 31 Dec 2013 | 150 | ||
| 1 Jan 2012 – 31 Dec 2012 | 150 | ||
| 1 Jan 2011 – 31 Dec 2011 | 135 | ||
| 1 Jan 2010 – 31 Dec 2010 | 156 | ||
| 1 Jan 2009 – 31 Dec 2009 | 150 | ||
| 1 Jan 2008 – 31 Dec 2008 | 161 | ||
| 1 Jan 2007 – 31 Dec 2007 | 160 | ||
| 1 Jan 2006 – 31 Dec 2006 | 144 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Flemming Sten Pedersen | Current | |
| Board | Flemming Sten Pedersen | Current | |
| Board | Svenn Ryberg Hansen | Current | |
| Board | Inge Holsted Hansen | Current | |
| Board | Claus Løndal Nielsen | ||
| Board | Allan Weimar Andersen | ||
| Board | Bjarne Grølsted-Kristensen | ||
| Owner (100%) | FPIH HOLDING ApS | Current | |
| Auditor | Revisionskontoret i Faxe | Current | |
| Auditor | MJAKP2 I/S | ||
| Auditor | PricewaterhouseCoopers, Statsautoriseret Revisionsinteressentskab | ||
| Auditor | PRICEWATERHOUSECOOPERS SERVICES STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | Sønderup I/S, statsautoriserede revisorer | ||
| Auditor | PRICEWATERHOUSECOOPERS STATSAUTORISERET REVISIONSPARTNERSELSKAB | ||
| Founder | Flemming Sten Pedersen | Current | |
| Founder | Allan Weimar Andersen | Current |
The CEOs' other companies
Flemming Sten Pedersen – 3 other companies
- FLEMMING STEEN PEDERSEN A/S Active
- FPIH HOLDING ApS Active
- WiCa ApS Active
Address history (0 moves)
| Åshøjvej 24, 4600 Køge |
Former names
| PHARMA TECHNOLOGY A/S | – now |
| LØNDAL PREPRESS A/S | – |
Employees per year
Other companies at the same address
- FLEMMING STEEN PEDERSEN A/S Active
- FPIH HOLDING ApS Active
Similar companies in Køge
- Dotbott ApS Køge
- Jenkins & Co. ApS Køge
- Technical Site Support & Management ApS Bjæverskov
- BOMU Engineering ApS Køge
- DeltaP ApS Køge
- ALNOVEX Group A/S Køge
- JeDar Consult ApS Køge
- Aconsil ApS Køge
- Danske Bolig ApS Bjæverskov
- UNI-TRAFO TECHNIC ApS Køge
- TAGE RIBERHOLT ApS Køge
- AHH Consulting ApS Køge
Questions and answers about PHARMA TECHNOLOGY A/S
Has PHARMA TECHNOLOGY A/S gone bankrupt?
No, PHARMA TECHNOLOGY A/S is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of PHARMA TECHNOLOGY A/S?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of PHARMA TECHNOLOGY A/S?
Flemming Sten Pedersen is the CEO of PHARMA TECHNOLOGY A/S.
Who is the auditor of PHARMA TECHNOLOGY A/S?
PHARMA TECHNOLOGY A/S most recently used Revisionskontoret i Faxe.
When was PHARMA TECHNOLOGY A/S founded?
PHARMA TECHNOLOGY A/S was founded on 31 March 1998.
What is the equity of PHARMA TECHNOLOGY A/S?
Equity was DKK 12.8m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.